The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 27, 2008
Filed:
Feb. 26, 2002
Christopher R. Tudan, Vancouver, CA;
Ahmed Merzouk, Richmond, CA;
Lakhdar Arab, Vancouver, CA;
Geeta Saxena, Vancouver, CA;
Connie J. Eaves, Vancouver, CA;
Johanne Cashman, Vancouver, CA;
Ian Clark-lewis, Vancouver, CA;
Hassan Salari, Delta, CA;
Christopher R. Tudan, Vancouver, CA;
Ahmed Merzouk, Richmond, CA;
Lakhdar Arab, Vancouver, CA;
Geeta Saxena, Vancouver, CA;
Connie J. Eaves, Vancouver, CA;
Johanne Cashman, Vancouver, CA;
Ian Clark-Lewis, Vancouver, CA;
Hassan Salari, Delta, CA;
The University of British Columbia, Vancouver, B.C., unknown;
Chemokine Therapeutics Corporation, Vancouver, B.C., unknown;
Abstract
In accordance with various aspects of the invention, CXCR4 agonists, including SDF-1 polypeptides and SDF-1 polypeptide homologues, may be used in reducing the rate of hematopoietic cell multiplication. Methods of the invention may comprise administration of an effective amount of an CXCR4 agonist to cells selected from the group consisting of hematopoietic stem cells and hematopoietic progenitor cells. Cells may be treated in vitro or in vivo in a patient. A therapeutically effective amount of the CXCR4 agonist may be administered to a patient in need of such treatment. Patients in need of such treatments may include, for example patients requiring bone marrow or peripheral blood stem cell transplantation.